| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Reuven Yeganeh | Director | 2026-03-17 | 530,000 | $2.00 | $1.06MBuy |
| Reuven Yeganeh | Director | 2026-03-17 | 530,000 | $5.00 | $2.65MSell |
| Reuven Yeganeh | Director | 2026-03-16 | 450,000 | $2.00 | $900.00kBuy |
| Reuven Yeganeh | Director | 2026-03-16 | 450,000 | $5.00 | $2.25MSell |
| Reuven Yeganeh | Director | 2026-03-13 | 370,000 | $2.00 | $740.00kBuy |
| Reuven Yeganeh | Director | 2026-03-13 | 370,000 | $5.00 | $1.85MSell |
| Reuven Yeganeh | Director | 2026-03-12 | 300,000 | $5.00 | $1.50MSell |
| Reuven Yeganeh | Director | 2026-03-11 | 300,000 | $2.00 | $600.00kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Orbimed Israel Biofund GP Limited Partnership | 135.75% | 13,773,653 | $7.16M | Insider |
| Erez Chimovits | 45.60% | 4,626,978 | $2.41M | Insider |
| Chidozie Ugwumba | 29.54% | 2,997,025 | $1.56M | Insider |
| James E. Flynn | 24.58% | 2,494,108 | $1.30M | Insider |
| Takeda Pharmaceutical Co Ltd | 24.35% | 2,470,935 | $1.28M | Insider |
| Jonas Grossman | 20.50% | 2,080,217 | $1.08M | Insider |
| Fibrosis Foundation Cystic | 17.62% | 1,787,758 | $929.63k | Insider |
| Gbolahan Amusa | 2.59% | 262,871 | $136.69k | Insider |
| Kerry Propper | 2.57% | 260,771 | $135.60k | Insider |
| Deerfield Management Company LP | 1.29% | 131,272 | $68.26k | Institution |